Johns Hopkins University

Seven years ago, I moved to Baltimore to begin my neuroscience Ph.D. studies at Johns Hopkins University, conducting science research funded by the NIH and NSF on how brain cells form connections with one another. These networks of cells are thought to be the basis of memory, and improper network formation could lead to cognitive disorders. We have utilized our knowledge of these mechanisms to diagnose and treat a variety of disorders caused by faulty cell-to-cell connections. As a student, I also found a passion in advocating for science. To improve my own communication skills, I founded Project Bridge, a student-led organization to foster public interest in science research by connecting...
Dear Research Advocate: Vice President Joe Biden continued the drumbeat for the Cancer Moonshot with a visit to Research!America member Johns Hopkins University on Tuesday. He spoke about the critical importance of the private sector in the discovery, development, delivery ecosystem. Indeed, from public-private partnerships to philanthropic donations, the private sector is an essential partner in the fight against deadly and debilitating diseases. Demonstrating both this point and his personal commitment to research, former New York Mayor --and Research!America Advocacy Award recipient-- Michael Bloomberg joined Sidney Kimmel and others in announcing a $125 million donation to create the...
Advocacy Academy participants: Mesias Pedroza, PhD, Baylor College of Medicine; Chloe N. Poston, PhD, Eli Lilly and Company; Jeffery G. Mellott, PhD Northeast Ohio Medical University Last week, we held our inaugural Advocacy Academy, bringing 12 postdoctoral researchers from across the U.S. to Washington, D.C. A two-day advocacy training program that culminated in Congressional visits with the participants’€™ representatives. We selected this group of motivated and concerned early-career scientists from a diversity of institutions, including Northeast Ohio Medical University, UCSF, Memorial Sloan-Kettering Cancer Center, Baylor College of Medicine, the University of Pennsylvania School of...
Advocacy Academy participants: Mesias Pedroza, PhD, Baylor College of Medicine; Chloe N. Poston, PhD, Eli Lilly and Company; Jeffery G. Mellott, PhD Northeast Ohio Medical University Last week, we held our inaugural Advocacy Academy, bringing 12 postdoctoral researchers from across the U.S. to Washington, D.C. A two-day advocacy training program that culminated in Congressional visits with the participants’€™ representatives. We selected this group of motivated and concerned early-career scientists from a diversity of institutions, including Northeast Ohio Medical University, UCSF, Memorial Sloan-Kettering Cancer Center, Baylor College of Medicine, the University of Pennsylvania School of...
Large medical centers across the U.S. are investing in a burgeoning area of healthcare for their cancer patients: €œprecision medicine. Substantial investments are being made to not only build new laboratory facilities and purchase research equipment, but also to staff these new facilities. Universities like Weill Cornell Medical College , Harvard Medical School , and Johns Hopkins University are joining clinical centers like Memorial Sloan-Kettering Cancer Center in building an infrastructure for personalized medicine with the hope of playing a bigger role in the development of new drugs. This approach is building off of years of federal investment in genomics research. First, the Human...
Dear Research Advocate, Congress has passed a spending bill for what remains of the current fiscal year, which ends September 30. Preliminary agency funding levels have been reported by Nature . The appropriations process remains important for making up some small amount of the ground lost to sequestration, but as long as sequestration remains the law of the land, annual cuts to NIH, FDA and our nation’€™s other health research agencies are all but assured ; and with it, the insidious ripple effect of damage to grantees, vendors, and the pharma, bio and device industries that partner with researchers to develop the products patients await. That’€™s the bottom line. We must remind our...

Sidebar Quote

We have health challenges in this country that science will provide answers for if given the chance and we haven't given science that opportunity
Mary Woolley, President and CEO, Research!America